The field of pharmaceutical formulation is constantly seeking innovative and effective ingredients to address pressing health concerns. Orlistat has emerged as a significant player in this domain, particularly in the development of therapies for obesity management. As a pharmaceutical intermediate, its primary function as a lipase inhibitor is crucial for formulating drugs that help reduce the absorption of dietary fats. This mechanism directly contributes to a caloric deficit, aiding individuals in their weight loss endeavors. The scientific basis for Orlistat's effectiveness lies in its molecular structure and its ability to interact with fat-digesting enzymes.

The precise specifications of Orlistat as a pharmaceutical ingredient are vital for its successful integration into drug products. Identified by CAS number 96829-58-2, this compound typically presents as a white crystalline powder. Its molecular formula, C29H53NO5, and molecular weight of 495.73, are standard data points for quality verification. The EINECS number 639-755-1 further aids in its identification within the chemical and pharmaceutical industries. For manufacturers, sourcing Orlistat that meets these exact specifications ensures the safety, efficacy, and regulatory compliance of their final products. This commitment to quality is a hallmark of responsible pharmaceutical development.

NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in this ecosystem by providing reliable access to high-purity Orlistat. Their commitment to supplying detailed product information, including COAs and MSDS, supports manufacturers in their formulation and quality assurance processes. The availability of such essential pharmaceutical intermediates, coupled with efficient logistics and responsive customer service, empowers companies to bring effective weight management solutions to market. The ongoing demand for obesity treatments means that pharmaceutical intermediates like Orlistat will remain in high demand, making strong supplier relationships a key factor for success.